Rotavirus Vaccines at 20 Years: Success, Challenges, and the Road Ahead
Open Access
Abstract
Twenty years after the introduction of rotavirus vaccines, the 15th International Rotavirus Symposium convened researchers, clinicians, immunization program managers, and policymakers to review advances in rotavirus epidemiology, immunology, vaccine development, and implementation. Rotavirus vaccination has contributed to sustained reductions in severe rotavirus hospitalizations and child mortality, yet population-level benefits remain heterogeneous and are constrained by gaps in coverage, supply-related program disruptions, and context-specific vaccine performance. Presenters highlighted evidence from multi-pathogen surveillance confirming that rotavirus remains a leading cause of pediatric diarrhea requiring hospitalization despite widespread vaccine introduction. Accumulating evidence implicates maternally derived antibodies, environmental enteric dysfunction, and early-life microbiome development as contributors to reduced oral vaccine performance in low- and middle-income communities, while recent studies of next-generation vaccine candidates underscore the need for improved correlates of protection and clinically meaningful efficacy endpoints. Collectively, the symposium emphasized that further reductions in rotavirus morbidity and mortality will require strengthening delivery of existing vaccines—including improving coverage, minimizing supply interruptions, and reaching zero-dose and under-immunized children—while sustaining surveillance and investing in integrated enteric disease prevention and next-generation vaccines to optimize protection in high-burden settings.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-067376)
- Bill and Melinda Gates Foundation (INV-006888)
This publication has 37 references indexed in Scilit:
- Rotasiil vaccine effectiveness against rotavirus-associated hospitalizations in the Democratic Republic of the Congo: comparison of multivariate logistic regression and inverse probability treatment weighting methods in a test-negative designVaccine, 2025
- Whole genome characterisation of DS-1-like G8P[4] rotavirus A strains circulating in South Africa between 2009 and 2021 reveals endemic sub-lineages and evidence of radical epitope changesInfection, Genetics and Evolution, 2025
- Challenges and lessons learned during the switching of rotavirus vaccine from Rotarix to Rotavac in ZambiaVaccine, 2025
- A decade of rotavirus vaccination in the World Health Organization African Region: An in-depth analysis of vaccine coverage from 2012 to 2023Vaccine, 2025
- Effectiveness of monovalent rotavirus vaccine against hospital-attended rotavirus gastroenteritis among children in UgandaVaccine, 2025
- Cost effectiveness analysis of rotavirus vaccination in IndonesiaVaccine, 2024
- Enteric virome negatively affects seroconversion following oral rotavirus vaccination in a longitudinally sampled cohort of Ghanaian infantsCell Host & Microbe, 2022
- Impact of rotavirus vaccines in Sub-Saharan African countriesVaccine, 2018
- Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 YearsJAMA Pediatrics, 2018
- Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept TrialCell Host & Microbe, 2018